- Market cap
- Revenue
- Net income
- Cash on hand
- Gross margin
- Net margin
- EPS
- P/E ratio
On July 1, 2015, DuPont completed the corporate spin-off of Chemours, which began trading on the New York Stock Exchange.
Chemours assumed various liabilities arising from lawsuits against DuPont.
In February 2024, CEO Mark Newman, CFO Jonathan Lock, and Financial Controller Camela Wisel were placed on administrative leave by the board of directors due to delayed payments to some vendors to increase their bonuses, in violation of the company's standards for ethics.